Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 31–45 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1920 AIP Genetic Test for Pituitary Adenoma (Prolactin-Secreting) This test evaluates the entire coding region of the AIP gene for germline mutations associated with hereditary pituitary adenomas.	Peripheral whole blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the AIP gene", "Copy Number Variants (CNVs) within the AIP gene"] Parameters [] Preparation ["Mandatory genetic counselling session prior to testing", "Construct a three-generation family pedigree", "No fasting or dietary restrictions required"] Indications ["Personal history of pituitary neoplasia", "Family history of pituitary neoplasia", "Suspicion of Familial Isolated Pituitary Adenoma (FIPA)"] Measurement technique Confirm with laboratory Codes LOINC: 81696-2 ICD-10: D35.2, E22.1, Z15.89 Clinical summary This test evaluates the entire coding region of the AIP gene for germline mutations associated with hereditary pituitary adenomas.
TEST-3580 AIPL1 Gene Cone-Rod Dystrophy Genetic Testing (NGS) Test This test evaluates the AIPL1 gene for pathogenic variants associated with cone-rod dystrophy using Next-Generation Sequencing (NGS). It identifies mutations linked to progressive...	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AIPL1 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation [] Indications ["Diagnosis of inherited cone-rod dystrophy", "Carrier status determination", "Family planning and recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 91831-1 ICD-10: H35.54 Clinical summary This test evaluates the AIPL1 gene for pathogenic variants associated with cone-rod dystrophy using Next-Generation Sequencing (NGS). It identifies mutations linked to progressive vision loss.
TEST-6363 ALG2 Gene Glycosylation Disorder Type 1I Genetic Test This genetic test identifies pathogenic variants in the ALG2 gene associated with congenital disorder of glycosylation type 1I (CDG‑1I). It confirms the molecular basis of this rar...	Whole Blood (EDTA tube or FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ALG2 gene", "Congenital disorder of glycosylation type 1I (CDG‑1I)"] Parameters [] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Suspected congenital disorder of glycosylation type 1I (CDG‑1I)", "Family history of CDG‑1I", "Unexplained multi-systemic symptoms suggestive of a metabolic disorder"] Measurement technique Confirm with laboratory Codes LOINC: 94219-5 ICD-10: E77.8 Clinical summary This genetic test identifies pathogenic variants in the ALG2 gene associated with congenital disorder of glycosylation type 1I (CDG‑1I). It confirms the molecular basis of this rare metabolic disorder.
TEST-1863 ALL Panel Deletion/Duplication Detection Test This test identifies clinically significant copy-number variations (deletions or duplications) in genes associated with acute lymphoblastic leukemia (ALL).	Bone marrow aspirate or peripheral blood	9–10 working days	1,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Copy number variations (deletions/duplications)", "Pathogenic variants in genes critical for ALL"] Parameters [] Preparation [] Indications ["Diagnosis of acute lymphoblastic leukemia", "Prognosis assessment in ALL", "Guiding personalized treatment selection in ALL"] Measurement technique Confirm with laboratory Codes LOINC: 88638-3 ICD-10: C91.00 Clinical summary This test identifies clinically significant copy-number variations (deletions or duplications) in genes associated with acute lymphoblastic leukemia (ALL).
TEST-202 AML Categorization PCR Test This test identifies specific gene mutations in leukemia cells to classify AML subtypes and inform targeted therapy.	Bone marrow aspirate or whole blood (lavender-top EDTA)	Mon samples by Wed, Thu samples by Sat	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Specific gene mutations (NPM1, FLT3-ITD, CEBPA, etc.)", "Molecular fingerprint of AML cells"] Parameters [] Preparation [] Indications ["Diagnosis of acute myeloid leukemia (AML)", "Prognostic stratification in AML", "Guidance for targeted therapy selection in AML"] Measurement technique Confirm with laboratory Codes LOINC: 88214-7 ICD-10: C92.00 Clinical summary This test identifies specific gene mutations in leukemia cells to classify AML subtypes and inform targeted therapy.
TEST-211 AML ETO t(8;21) Gene Rearrangement PCR Qualitative Test This diagnostic test evaluates for the presence of the RUNX1-RUNX1T1 fusion transcript, indicative of the t(8;21) translocation in acute myeloid leukemia.	Bone Marrow Aspirate or Peripheral Blood	48–72 hours from sample receipt	900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RUNX1-RUNX1T1 fusion transcript"] Parameters [{"name": "RUNX1-RUNX1T1 fusion transcript", "reference_range": "Negative"}] Preparation ["No special preparation required", "Inform referring physician of anticoagulant or antiplatelet use"] Indications ["Diagnosis of acute myeloid leukemia", "Risk stratification in AML", "Minimal residual disease (MRD) monitoring in AML"] Measurement technique Confirm with laboratory Codes LOINC: 49908-2 ICD-10: C92.5 Clinical summary This diagnostic test evaluates for the presence of the RUNX1-RUNX1T1 fusion transcript, indicative of the t(8;21) translocation in acute myeloid leukemia.
TEST-1854 AML Panel Deletion/Duplication Detection Test This test evaluates the presence of deletions or duplications in specific genes commonly associated with Acute Myeloid Leukemia (AML).	Bone Marrow Aspirate or Peripheral Blood	7–10 days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Gene deletions", "Gene duplications", "AML-associated genes"] Parameters [] Preparation [] Indications ["Diagnosis of AML", "Prognosis assessment in AML", "Guidance for targeted therapy selection in AML"] Measurement technique Confirm with laboratory Codes LOINC: 93385-0 ICD-10: C92.00 Clinical summary This test evaluates the presence of deletions or duplications in specific genes commonly associated with Acute Myeloid Leukemia (AML).
TEST-1848 AML PCR Panel (AML/ETO, inv(16), PML/RARA) Test This test detects the presence and quantity of three specific genetic fusion transcripts associated with high-risk acute myeloid leukemia.	Bone Marrow Aspirate or Peripheral Blood	5–6 Business Days	1,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AML1-ETO fusion transcript", "inv(16)/CBFB-MYH11 fusion transcript", "PML-RARA fusion transcript"] Parameters [] Preparation [] Indications ["Diagnosis of acute myeloid leukemia (AML)", "Risk stratification in AML", "Monitoring minimal residual disease (MRD) in AML", "Guiding targeted therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 53500-9 (Panel), 53498-6 (AML1/ETO), 53501-7 (CBFB/MYH11), 53504-1 (PML/RARA) ICD-10: C92.00, C92.01, C92.02 Clinical summary This test detects the presence and quantity of three specific genetic fusion transcripts associated with high-risk acute myeloid leukemia.
TEST-1850 AML Prognostic Panel (Cytogenetics + PCR) Test This test evaluates for key chromosomal abnormalities and gene mutations associated with Acute Myeloid Leukemia (AML) to determine risk stratification.	Bone Marrow Aspirate (preferred) / Peripheral Blood (alternative)	5–7 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Structural chromosomal rearrangements (e.g., AML1-ETO, INV(16), PML-RARA)", "Gene mutations (e.g., FLT3-ITD/TKD, NPM1, CEBPA)"] Parameters [{"name": "Karyotype", "reference_range": "Normal human karyotype (46,XX or 46,XY)"}, {"name": "AML1-ETO (RUNX1-RUNX1T1) Fusion", "reference_range": "Negative / Positive"}, {"name": "CBFB-MYH11 (INV(16)) Fusion", "reference_range": "Negative / Positive"}, {"name": "PML-RARA Fusion", "reference_range": "Negative / Positive"}, {"name": "FLT3-ITD Mutation", "reference_range": "Negative / Positive (Allele burden reported if positive)"}, {"name": "FLT3-TKD Mutation", "reference_range": "Negative / Positive"}, {"name": "NPM1 Mutation", "reference_range": "Negative / Positive"}, {"name": "CEBPA Mutation", "reference_range": "Negative / Positive (Biallelic status reported)"}] Preparation ["No specific fasting required.", "Inform the physician of all current medications."] Indications ["Diagnosis of Acute Myeloid Leukemia (AML)", "Risk stratification for treatment planning", "Prognostic assessment", "Eligibility assessment for clinical trials"] Measurement technique Confirm with laboratory Codes LOINC: 88277-7 ICD-10: C92.0 Clinical summary This test evaluates for key chromosomal abnormalities and gene mutations associated with Acute Myeloid Leukemia (AML) to determine risk stratification.
TEST-3238 AMN Gene Megaloblastic Anemia Type 1 Genetic Test This test identifies pathogenic variants in the AMN gene associated with hereditary cobalamin malabsorption (Imerslund-Gräsbeck syndrome).	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AMN gene", "Full coding region and conserved splice sites"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab of any current medications."] Indications ["Suspected hereditary cobalamin malabsorption", "Family history of megaloblastic anemia or Imerslund-Gräsbeck syndrome", "Differentiation from acquired pernicious anemia"] Measurement technique Confirm with laboratory Codes LOINC: 93371-3 ICD-10: D51.1, E53.8 Clinical summary This test identifies pathogenic variants in the AMN gene associated with hereditary cobalamin malabsorption (Imerslund-Gräsbeck syndrome).
TEST-6086 AMPD3 Gene AMP Deaminase Deficiency (Erythrocytic) Genetic Test This genetic test identifies pathogenic variants in the AMPD3 gene associated with erythrocytic adenosine monophosphate deaminase deficiency.	Peripheral whole blood (EDTA)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AMPD3 gene", "SNVs, indels, CNVs"] Parameters [] Preparation ["Do not discontinue, modify, or skip any prescribed medication or supplement in preparation for this test.", "Consult your treating physician first."] Indications ["Symptomatic patients", "At-risk families", "Health-optimisation seekers", "Diagnosis of hereditary AMP deaminase deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 96778-1 ICD-10: D55.2 Clinical summary This genetic test identifies pathogenic variants in the AMPD3 gene associated with erythrocytic adenosine monophosphate deaminase deficiency.
TEST-4206 ANK2 Gene Long QT Syndrome Type 4 Genetic Test This test evaluates the entire ANK2 gene for mutations associated with Long QT Syndrome Type 4 (LQTS4), a hereditary cardiac arrhythmia.	Whole Blood (Peripheral Venous Blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ANK2 gene sequence", "Copy number variants (CNVs) within the ANK2 gene"] Parameters [{"name": "ANK2 Gene Sequencing", "reference_range": "Full gene coverage including intronic regions"}, {"name": "Analytical Sensitivity", "reference_range": "99.9%"}, {"name": "Copy Number Variant (CNV) Detection", "reference_range": "Included"}] Preparation ["Genetic counselling is mandatory before sample collection."] Indications ["Diagnosis of Long QT Syndrome Type 4 (LQTS4)", "Cascade screening of family members", "Risk stratification for sudden cardiac events"] Measurement technique Confirm with laboratory Codes LOINC: 93723-0 ICD-10: I45.81, Z13.7, Z15.89 Clinical summary This test evaluates the entire ANK2 gene for mutations associated with Long QT Syndrome Type 4 (LQTS4), a hereditary cardiac arrhythmia.
TEST-3811 ANLN Gene Focal Segmental Glomerulosclerosis Type 8 (FSGS8) Genetic Test This genetic test identifies pathogenic variants in the ANLN gene associated with autosomal dominant focal segmental glomerulosclerosis type 8 (FSGS8).	Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ANLN gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting required", "Mandatory genetic counselling session prior to collection"] Indications ["Suspected FSGS8", "Familial risk assessment for FSGS8", "Diagnosis confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: N04.1 Clinical summary This genetic test identifies pathogenic variants in the ANLN gene associated with autosomal dominant focal segmental glomerulosclerosis type 8 (FSGS8).
TEST-4831 ANO5 Gene Limb‑Girdle Muscular Dystrophy Type 2L (LGMD2L) Genetic Test This test detects pathogenic variants in the ANO5 gene, providing a definitive diagnosis for autosomal recessive Limb-Girdle Muscular Dystrophy Type 2L (LGMD2L).	Whole Blood (2 mL)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ANO5 gene sequence", "Copy Number Variants (CNVs) in ANO5 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Clinical suspicion of LGMD2L", "Family history of LGMD2L", "Need for definitive diagnosis for management and family planning"] Measurement technique Confirm with laboratory Codes LOINC: 85047-9 ICD-10: G71.0 Clinical summary This test detects pathogenic variants in the ANO5 gene, providing a definitive diagnosis for autosomal recessive Limb-Girdle Muscular Dystrophy Type 2L (LGMD2L).
TEST-3719 ANOS1 Gene Kallmann Syndrome Type 1 Genetic Test This test identifies pathogenic variants in the ANOS1 gene, confirming a diagnosis of Kallmann Syndrome Type 1.	Peripheral whole blood, extracted DNA, or buccal swab	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ANOS1 gene sequence", "Pathogenic variants in ANOS1"] Parameters [] Preparation ["No fasting or dietary restrictions required", "Maintain current medications unless advised otherwise by endocrinologist", "Mandatory pre-test genetic counseling session at least 48 hours prior"] Indications ["Congenital hypogonadotropic hypogonadism with anosmia", "Delayed puberty", "Infertility investigation"] Measurement technique Confirm with laboratory Codes LOINC: 81321-3 ICD-10: E23.0 Clinical summary This test identifies pathogenic variants in the ANOS1 gene, confirming a diagnosis of Kallmann Syndrome Type 1.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories